Trials / Completed
CompletedNCT06415617
Home-based Psychoeducation for Older Adults With Frailty: A Feasibility Trial
Effects of A Home-based Psychoeducation Programme on Subjective Well-being for Older Adults With Frailty in the Community: A Feasibility Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- TAO An · Academic / Other
- Sex
- All
- Age
- 65 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to test the feasibility and acceptability of home-based psychoeducation in older adults with frailty in the community. The main questions it aims to answer are 1. Are the proposed eligibility criteria for participants and the study process in recruiting and retaining the participants appropriate? 2. Is home-based psychoeducation feasible and acceptable for older adults with frailty in the community? Participants will receive 12 weekly online group-based sessions at their homes. The content for the experimental group and control group is different: * Intervention group: psychoeducation * Control group: physical health education Participants will receive two home visits for data collection. An individual interview will be conducted with participants in the experimental group to explore their experiences.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Psychoeducation | The content of psychoeducation is based on "Five Ways of Well-being" which covers "Be active", "Connect", "Take Notice", "Keep learning" and "Giving" . The participants will be engaged in psychoeducation through group discussion, individualised goal setting and reflective exercises. |
| OTHER | Attention control | The content of the sessions mainly focuses on physical health information, such as healthy eating, physical exercise, prevention of falls, and pain management. |
Timeline
- Start date
- 2023-11-24
- Primary completion
- 2024-04-09
- Completion
- 2024-04-09
- First posted
- 2024-05-16
- Last updated
- 2024-05-16
Locations
1 site across 1 country: Hong Kong
Source: ClinicalTrials.gov record NCT06415617. Inclusion in this directory is not an endorsement.